Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,425
Active & Responsive
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Location: Tampa FL, Jacksonville FL, Columbus OH, St Louis MO,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06682793
Phase 1, Phase 2, Recruiting
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: Tampa FL, Atlanta GA, Winston-Salem NC, Durham NC,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase 2, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Tampa FL, Palm Bay FL, Jacksonville FL, Charleston SC,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: Tampa FL, Miami FL, Jacksonville FL, Atlanta GA,
Sponsor: Disc Medicine, Inc
Sex: All
Age: 18+
Code: NCT05320198
Phase 1, Phase 2, Recruiting
Active & Responsive
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for
Solid Tumor, Adult, Colorectal Cancer,
Location: Tampa FL, Jacksonville FL, Nashville TN, Columbus OH,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT04981119
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of REM-422 in Patients With AML or Higher Risk MDS
for
Myelodysplastic Syndromes,
Location: Tampa FL, Houston TX, New York NY, Boston MA, Duarte CA
Sponsor: Remix Therapeutics
Sex: All
Age: 18+
Code: NCT06297941
Phase 1, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: Tampa FL, Jacksonville FL, Nashville TN, Columbus OH,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Tampa FL, Orlando FL, Coral Springs FL, Jacksonville FL,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase 1, Recruiting
Active & Responsive
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for
Metastatic Non-small Cell Lung Cancer
Location: Tampa FL, Ocala FL, Jacksonville FL, Birmingham AL,
Sponsor: NovoCure GmbH
Sex: All
Age: 18+
Code: NCT06216301
Phase 3, Recruiting
Active & Responsive
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
for
Non-small Cell Lung Cancer
Location: Tampa FL, Birmingham AL, Elizabethtown KY, New York NY
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06841055
Phase 2, Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for
Metastatic Colorectal Cancer
Location: Tampa FL, Baton Rouge LA, Nashville TN, Webster TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT04929223
Phase 1, Recruiting
Active & Responsive
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
for
Myelofibrosis (PMF),
Location: Tampa FL, Atlanta GA, Winston-Salem NC, Columbus OH,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT05835466
Phase 2, Recruiting
Active & Responsive
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
for
Glioblastoma, IDH-Wildtype
Location: Tampa FL, Jacksonville FL, Atlanta GA, Birmingham AL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06319027
Phase 2, Recruiting
Active & Responsive
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Tampa FL, Jacksonville FL, Providence RI, Rochester MN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07805954
Phase 3, Recruiting
Active & Responsive
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
for
Colorectal Cancer
Location: Tampa FL, Coral Springs FL, Tamarac FL, Chapel Hill NC,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659795
Phase 2, Recruiting
Active & Responsive
Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors
for
Smoking Cessation, Alcohol Use
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT07447635
Recruiting
Active & Responsive
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
for
FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Location: Tampa FL, Houston TX, Chicago IL, New York NY,
Sponsor: Elevar Therapeutics
Sex: All
Age: 18+
Code: NCT07359820
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Tampa FL, Atlanta GA, Hackensack NJ, Boston MA,
Sponsor: Kelonia Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07075185
Phase 1, Recruiting
Active & Responsive
A Study of TAK-505 in Adults With Solid Tumors
for
Malignant Solid Tumors
Location: Tampa FL, Nashville TN, Houston TX, Fairfax VA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07436728
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII